Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

injectable

injectable is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 20
Pipeline programs 106
News articles 0
Drug details — injectable
Class
—
Route
—
Patents
20
Programs
106
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

injectable is an FDA-listed pharmaceutical active ingredient.

Key facts

INN injectable

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Browse pipeline
  1. 2023/3720 UMBRELLA Phase 3 · George Institute for · patients with a positive status for molecular residual disea
  2. ABX-CT-302EU/EAGLE-i Phase 3 · Advanced Accelerator Applications · Prostate Cancer
  3. APHP180588 Phase 3 · PARItec · early syphilis
  4. APHP200011 Phase 3 · PARItec · Intensive care, Ventilator Associated Pneumonia
  5. APHP211034 Phase 3 · PARItec · patients hospitalized in ICU with ESBL-producing Enterobacte
  6. APHP211035 Phase 3 · PARItec · vaso-occlusive crisis due to sickle cell disease
  7. APHP211046 Phase 3 · PARItec · Any patients ≥18 years old, eligible for transfemoral TAVI w
  8. APHP220668 Phase 3 · PARItec · Major depressive disorder with current severe major depressi

Related patents

Browse patents

  1. US 12318401

    Injectable shear-thinning hydrogel containing therapeutic agent for enhanced tumor therapy

    Expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12102682

    Injectable photothermal hydrogel based on melanin, preparation method, and application thereof

    Expires Mon Sep 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11850325

    Injectable, bioadhesive cryogel scaffolds for biomedical uses

    Expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11446238

    Injectable dendrimer hydrogel nanoparticles

    Expires Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11426418

    Injectable long-acting semi-solid gel formulations

    Expires Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11219604

    Injectable sustained release composition and method of using the same for treating inflammation in joints and pain associated therewith

    Expires Mon Jan 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11191842

    Injectable thermoresponsive polyelectrolytes

    Expires Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. CA 3133787

    GELS HOMOGENES INJECTABLES COMPRENANT DE MULTIPLES FORMES D'ACIDE HYALURONIQUE ET LEURS PROCEDES DE FABRICATION

    Expires Wed Sep 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. WO 2020094634

    PROMÉDICAMENTS DE THIOPHÈNE DE NALTROXÈNE POUR COMPOSITIONS INJECTABLES À ACTION PROLONGÉE ET PROCÉDÉS ASSOCIÉS

    Expires Wed May 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 10561606

    Injectable long-acting local anesthetic semi-solid gel formulations

    Expires Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 2020017529

    NOVEL THIENOTHIOPHENE COMPOUNDS FOR LONG-ACTING INJECTABLE COMPOSITIONS AND RELATED METHODS

    Expires Wed Jan 11 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 2020016151

    NOVEL NAPHTHYLENYL COMPOUNDS FOR LONG-ACTING INJECTABLE COMPOSITIONS AND RELATED METHODS

    Expires Wed Jan 11 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 10500281

    Injectable long-acting local anesthetic semi-solid formulations and its compositions

    Expires Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9987233

    Injectable sustained release composition and method of using the same for treating inflammation in joints and pain associated therewith

    Expires Mon May 31 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9844600

    Injectable thermoresponsive polyelectrolytes

    Expires Mon Dec 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9801812

    Injectable non-aqueous compositions and methods of treating vascular disease

    Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9724367

    Injectable formulations for organ augmentation

    Expires Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9655842

    Injectable non-aqueous compositions and methods of treating vascular disease

    Expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9220676

    Injectable in-situ crosslinked hydrogel and methods of making and using thereof

    Expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9200077

    Injectable solution containing therapeutic agent for osteoarthritis

    Expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is injectable?

injectable is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.